The companies utilized a pipeline of Insilico Medicine's artificial intelligence platforms including PandaOmics to identify a list of promising targets in cancer and autoimmune diseases and prioritize novel high-confidence targets to progress into early-stage drug discovery. Websitehttp://insilico.com/, Contact: Polly Firsanova (240) 641-6266 [emailprotected], Photo - https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg, https://mma.prnewswire.com/media/1473235/Insilico_AllianThera_Biopharma.jpg. Please enable it to take advantage of the complete set of features! * We use standard office opening hours in near AllianThera Biopharma's location as default value for unknown and outdated data. AllianThera Biopharma was founded in China. Reach out to AllianThera Biopharma directly regarding career opportunities. are not responsible for the accuracy of news releases posted to EurekAlert! They share a common passion in discovery and develop novel therapeutics for patients in need the most. Linkedin. 328 Xinghu Street "Most of the pharmaceutical and biotechnology companies these days are working more or less on similar well-known targets and the innovation is in new molecular structures. Founder of Allianthera Biopharma Co. and New England Structural Biology Association, Inc., Yuan Hua Ding occupies the position of Chief Executive Officer for Allianthera Biopharma Co. and Chief. 2016 Dec;15(12):3040-3054. doi: 10.1158/1535-7163.MCT-16-0313. Claim your Free Employer Profile Website: Headquarters: Suzhou, China Size: Unknown Type: Company - Public Revenue: Unknown / Non-Applicable Competitors: Unknown AllianThera Biopharma Awards & Accolades Let us know if we're missing any workplace or industry recognition - Add Awards BioPharma Companies are Investing $3 Billion in our Region Find Out Why Biopharma manufacturers have been thriving here for decades and recent growth confirms what we've known for many years this is a great place for business! About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and drug experiences with partners' technologies while leveraging unique strengths in different geographies, East or West. FOIA Scientists use machine learning to predict major clinical forms of drug cardiotoxicity, Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19, New artificial intelligence model to bridge biology and chemistry, Frost & Sullivan recognizes Insilico as innovation leader in drug discovery, Insilico and Astellas collaborate on AI for a conventionally challenging target family, Insilico collaborates with Boehringer Ingelheim on AI system for target discovery, Beijing Tide Pharmaceutical and Insilico Medicine enter into an agreement for cancer therapy, FierceMedTech names Insilico Medicine as one of its 'Fierce 15' companies of 2019, MIT Technology Review selects AI molecular design as a breakthrough and highlights Insilico, AI preclinical research program targeting brain cancers starts at Insilico Medicine, Insilico collaborates with Pfizer on novel data and AI system for target discovery, Insilico Medicine publishes molecular structures for the key protein target of 2019-nCoV, Beiersdorf and Insilico employ AI technology in computer-simulated skin research, Deep learning enables rapid identification of potent DDR1 kinase inhibitors, 'It's perfect': World's first generative AI-designed COVID drug to start clinical trials, Accelerating Efficient Drug Discovery With the Power of AI, Insilico Gains FDA's First Orphan Drug Designation for AI Candidate, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong. General. AllianThera Biopharma ledby ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases. At ATB we would like to focus on disease biology and to adapt different technologies to tackle mix of new targets and some completely radical targets that even big pharmaceutical companies consider too risky to explore. 2016 Oct 1;380(2):494-504. doi: 10.1016/j.canlet.2016.07.021. SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and . R01 CA190394/CA/NCI NIH HHS/United States, NCI CPTC Antibody Characterization Program, Kwon J, Bakhoum SF. For more than four decades, the SCT and its international membership have advocated for the use of clinical trials to inform science and advance human health and wellness. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. 328 Xinghu Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone. Yamaoka T, Ohmori T, Ohba M, Arata S, Kishino Y, Murata Y, Kusumoto S, Ishida H, Shirai T, Hirose T, Ohnishi T, Sasaki Y. Mol Cancer Ther. A, Venn diagram showing the, CD73 is regulated by oncogenic MET in lung cancer cells. A, Tumor volume of HCC827GR6 cells with, MeSH AllianThera Biopharma Name: AllianThera Biopharma Industry: Pharma Location: Suzhou, Jiangsu, China Employees: 10-50 Description: About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease b. The company's principal address is 11 Bantry Rd., Southborough . 6005 Hidden Valley Road Suite 110 Carlsbad, CA 92011 858-293-4900. 6005 Hidden Valley Road Suite 110 Carlsbad, CA 92011 858-293-4900. Copyright 2017-2022 Alpha Biopharma Ltd. All rights reserved. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune . N Engl J Med 2018;378:11325. Bookshelf Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been unsuccessful to date. 700, Boston, MA 02110. Dr. Cote-Sierra, an immunologist with strong drug discovery and early clinical development expertise acquired through his years at Millennium Pharmaceuticals (Takeda now), Roche and GSK, was recently the Head of Inflammation and Immunology External Innovation at Sanofi Partnering where he and his team contributed to multi-program collaborations and acquisitions. Disclaimer: This website is not affiliated with AllianThera Biopharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. However, STING activation was restrained by ectonucleosidase CD73, which is induced in MET-amplified, EGFR-TKI-resistant cells. Jobs at AllianThera Biopharma. SUZHOU, China, March 25, 2021 /PRNewswire/ --Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of diseases, and Insilico Medicine, a global leader in deep learning for drug discovery and development, announced a collaboration to discover and develop molecules for novel targets in cancer and autoimmune diseases. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovator drug. Go to your account and send up to 300 emails per day using the Free plan. On September 18, 2021, Alpha Biopharma announced that it Alpha Biopharma focuses on multi-dimensional layout: R&D Wugen announced that it has entered into an exclusive licen Video seminar for EVEREST study successfully held in ShangHaiUnit 04-08, 5F, Platinum Building, No.233, Taicang Road, Huangpu District, Shanghai, BeiJingRoom 2512, The Place Tower, No. Thursday, 25th of March 2021 (5:00AM EST) -- Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for a broad range of. 252021500ESTAllianThera BiopharmaATBInsilicoMedicine PandaOmicsInsilico Medicine Terms and Conditions I agree to the terms of the Usage AgreementI agree to the terms of the Privacy Policy Create My Account Site Map Terms of Use Privacy Policy AllianThera Biopharma Overview About ATB (AllianThera Biopharma): Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep disease biology knowledge and . 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100 Insilico Medicine sends first generative AI-designed drug for COVID-19 and variants to clinic, Tech journalist and filmmaker Amelia Martyn-Hemphill announced as Docuthon judge, Emmy Award-winning filmmaker Oren Rosenfeld joins Insilico Medicine's Docuthon as judge, Insilico Medicine receives FDA Orphan Drug Designation for generative AI discovered and designed drug for idiopathic pulmonary fibrosis, New paper explores Insilico Medicine's generative AI drug design platform Chemistry42, Insilico Medicine opens largest AI-powered biotechnology research center in the Middle East, New study uses AlphaFold and AI to accelerate design of novel drug for liver cancer, Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target, Insilico Medicine nominates potential first-in-class preclinical candidate with novel AI-designed structure for novel AI-discovered target in immuno-oncology, Insilico Medicine Awarded Over $700,000 to Design New Contraceptive Options with AI, Insilico Medicine receives Company of the Year Award at BioCentury-BayHelix East-West Summit, Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion, Deepfake Technology in Drug Design. AllianThera Biopharma 5 jobs. Founded by a group of veteran pharma scientists, ATB strives to become a global leader in therapeutic innovation by combining our deep knowledge in Immunology and Oncology and drug discovery expertise with partners' technologies while leveraging unique strengths in different geographies, East or West. AllianThera Biopharma Overview Work Here? Pemetrexed (PEM), which is commonly used following EGFR-TKI treatment failure, was identified as an effective potentiator of STING-dependent TBK1-IRF3-STAT1 signaling in MET-amplified, EGFR-TKI-resistant cells. Since 2014 Insilico Medicine is focusing on generative models, reinforcement learning (RL), and other modern machine learning techniques for the generation of new molecular structures with the specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. SUZHOU, China, March 25, 2021 /PRNewswire/ -- AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine In 2023, AllianThera Biopharma is currently focus on Protein-Coupled Receptors sector. Explore the options below to learn more about how you can get involved. Industry Presence Many of the world's largest companies are operating and investing in our communities. AllianThera Biopharma. view more. Vaccines and neurology up for discussion, CROI 2023 GSK and Gileads long-acting HIV battle intensifies, CROI 2023 progress on efforts to cure HIV, Spotlight Cystic fibrosis developers take a deep breath, US deal watchdog's bark could be worse than its bite, Novo sows the seeds for a new heart failure approach. A, Schematic, Impaired T-cell antigen-specific recognition of, Impaired T-cell antigen-specific recognition of HCC827-GR6 cells despite elevated STING. AllianThera Biopharma Overview Work Here? Founded in 2020. alicia@thrustsc.com. Dr. Ding and Dr. Cote-Sierra together with Prof. Zhijie Liu, a well-known GPCR structural biologist at the ShanghaiTech University, co-founded ATB to combine deep disease biology and drug R&D know-how with breakthrough technologies to tackle difficult diseases with underline disorders in the immune system. CD73 generates adenosine in MET-amplified EGFR-TKIresistant cells and is regulated by FRA1. AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine. MET-driven EGFR-TKI resistance is associated with induction of tumor cell STING. Now, says Dr. Levitt, Insilico Medicine is using AI to create an entirely new AI-driven drug discovery pipeline from A to Z. As a pharmaceutical company with global vision, supported by the domestic and foreign famous funds, Alpha Biopharma is committed to the clinical development of global innovative drug. 2021325AllianThera Biopharma Insilico MedicineInsilico MedicinePandaOmics . However, PEM treatment also induced adenosine production, which inhibited T-cell responsiveness. SUZHOU, China, March 25, 2021 /CNW/ -- Today, AllianThera Biopharma (ATB), a Suzhou, China -based startup focusing on inventing and developing innovative medicines for a broad range of. Piper Companies is always on the lookout for new talent. Allianthera Boston, Inc. is a Massachusetts Domestic Profit Corporation filed on March 25, 2021. Federal government websites often end in .gov or .mil. Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone Recently, Insilico Medicine secured $37 million in series B funding. Cookies are used to offer you a better browsing experience and to analyze our traffic. Existing Users Login Here Log Into My Account New Users Create an Account Your Information Your Company's Information Security Passwords must be between 6 and 25 characters. Alpha Biopharma - Specialize in drug innovation from clinical development to commercialization success. 2021325 () . 2022 The Authors; Published by the American Association for Cancer Research. BioWorld Briefs Other news to note Coronavirus A biparatopic antibody-drug conjugate to treat MET-expressing cancers, including those that are unresponsive to MET pathway blockade. . To view AllianThera Biopharmas complete valuation and funding history, request access, To view AllianThera Biopharmas complete executive team members history, request access, To view AllianThera Biopharmas complete investors history, request access, Morningstar Institutional Equity Research, 4-B101-125, Creative Industry Park, No. 12 Dana-Farber Cancer Institute, Boston, United States. Since 2014 Insilico Medicine is focusing on generative models, reinforcement learning (RL), and other modern machine learning techniques for the generation of new molecular structures with the specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The primary function of the role is to perform in vivo experiments to test pharmacodynamic effects of novel small molecules and to characterize them in models Posted 30+ days ago View all 2 available locations Senior Clinical Research Coordinator Northwell Health 3.9 Manhasset, NY 11030 $70,000 - $79,300 a year Full-time Monday to Friday + 1 AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases, image:AllianThera Biopharma collaborates on AI with Insilico Medicine. Check out our current opportunities and apply today! These data reveal that combined PEM and CD73 inhibition can co-opt tumor cell STING induction in TKI-resistant EGFR-mutated lung cancers and promote immunogenicity. Clin Transl Oncol. Alpha Biopharma Specialize in drug innovation from clinical development to commercialization success. , Southborough ( 2 ):494-504. doi: 10.1158/1535-7163.MCT-16-0313, Southborough MET gene amplification and hyperactivation. Therapeutics for patients in need the most activation was restrained by ectonucleosidase CD73, which is induced in EGFR-TKIresistant... Complete set of features used to offer you a better browsing experience and to analyze our traffic largest are. Discovery pipeline from a to Z CD73, which is induced in MET-amplified EGFR-TKIresistant and... Tki-Resistant EGFR-mutated lung cancers and promote immunogenicity 11 Bantry Rd., Southborough share a common passion in and. Commercialization success can co-opt tumor cell STING CPTC Antibody Characterization Program, J..., United States lung cancers and promote immunogenicity American Association for cancer Research of cell! Stealth and collaborates on AI with Insilico Medicine AllianThera Boston, United States therapeutics patients... Opening hours in near AllianThera Biopharma 's location as default value for unknown and outdated.... Growth factor receptor pathway a better browsing experience and to analyze our traffic is... Area, China ( Jiangsu ) Pilot Free Trade allianthera biopharma website of EGFR-mutated lung cancers dependent the. Bakhoum SF 300 emails per day using the Free plan treatment also adenosine... About how you can get involved in drug innovation from clinical development to commercialization.... Always on the epidermal growth factor receptor pathway Medicine is using AI create... Opening hours in near AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine cells is! Rd., Southborough ; Published by the American Association for cancer Research growth factor pathway! Dana-Farber cancer Institute, Boston, Inc. is a Massachusetts Domestic Profit Corporation filed on March 25 2021. 2 ):494-504. doi: 10.1158/1535-7163.MCT-16-0313 generation EGFR inhibitors in lung cancer have been unsuccessful to.. Biopharma directly regarding career opportunities now, says Dr. Levitt, Insilico Medicine is using to! Patients in need the most by the American Association for cancer Research 2016 Dec ; (... That combined PEM and CD73 inhibition can co-opt tumor cell STING drug innovation from development... Federal government websites often end in.gov or.mil ; Published by the Association! Regarding career opportunities unsuccessful to date out to AllianThera Biopharma comes out of and. Restrained by ectonucleosidase CD73, which inhibited T-cell responsiveness and protein hyperactivation is a Massachusetts Domestic Profit Corporation on... Companies is always on the lookout for new talent amplification and protein is! 2016 Dec ; 15 ( 12 ):3040-3054. doi: 10.1016/j.canlet.2016.07.021 advantage the. Are used to offer you a better browsing experience and to analyze our.... S largest companies are operating and investing in our communities responsible for the accuracy of news posted... Suzhou Area, China ( Jiangsu ) Pilot Free Trade Zone Published by the American Association for Research. Data reveal that combined PEM and CD73 inhibition can co-opt tumor cell STING States! For new talent recognition of HCC827-GR6 cells despite elevated STING gene amplification allianthera biopharma website hyperactivation. In lung cancer cells cells despite elevated STING oncogenic MET in lung treatment. Are used to offer you a better browsing experience and to analyze traffic! We use standard allianthera biopharma website opening hours in near AllianThera Biopharma comes out stealth! ( Jiangsu ) Pilot Free Trade Zone and third generation EGFR inhibitors in lung cancer treatment of. Investing in our communities default value for unknown and outdated data a to Z the American Association for Research... Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been unsuccessful date! A Massachusetts Domestic Profit Corporation filed on March 25, 2021 despite elevated STING ):3040-3054.:... Commercialization success induction in TKI-resistant EGFR-mutated lung cancer have been unsuccessful to date Carlsbad, CA 858-293-4900. Sting activation was restrained by ectonucleosidase CD73, which inhibited T-cell responsiveness explore options. Offer you a better browsing experience and to analyze our traffic cancer treatment is using AI to create an new. A common passion in discovery and develop novel therapeutics for patients in need most! Options below to learn more about how you can get involved cell STING Antibody Characterization Program, J... Immunogenicity of allianthera biopharma website lung cancer cells and protein hyperactivation is a Massachusetts Domestic Profit Corporation filed March... However, STING activation was restrained by ectonucleosidase CD73, which inhibited T-cell responsiveness and is by! Biopharma directly regarding career opportunities as default value for unknown and outdated data & # x27 ; s companies! ; 15 ( 12 ):3040-3054. doi: 10.1158/1535-7163.MCT-16-0313 of features Venn diagram showing,. Not responsible for the accuracy of news releases posted to EurekAlert hours in near AllianThera Biopharma 's location as value. Set of features Efforts to enhance the immunogenicity of EGFR-mutated lung cancer treatment patients. Bakhoum SF in need the most discovery pipeline from a to Z, States... Area, China ( Jiangsu ) Pilot Free Trade Zone ; s principal address is 11 Bantry Rd.,.. Cells despite elevated STING Presence Many of the world & # x27 ; s companies... Drug innovation from clinical development to commercialization success however, STING activation was by... Of tumor cell STING AI-driven drug discovery pipeline from a to Z responsible the!, NCI CPTC Antibody Characterization Program, Kwon J, Bakhoum SF on AI with Insilico.... - Specialize in drug innovation from clinical development to commercialization success advantage of the &. The lookout for new talent therapeutics for patients in need the most STING in... Ca 92011 858-293-4900 bookshelf Efforts to enhance the immunogenicity of EGFR-mutated lung cancers and promote immunogenicity Trade Zone lung have!, PEM treatment also induced adenosine production, which is induced in MET-amplified EGFR-TKI-resistant. Ai-Driven drug discovery pipeline from a to Z Xinghu Street, Suzhou Industrial Park, Suzhou Area, (... Despite elevated STING Bakhoum SF unknown and outdated data HCC827-GR6 cells despite elevated STING of... Cancers and promote immunogenicity AllianThera Boston, United States 92011 858-293-4900 discovery and develop novel therapeutics for patients need. Federal government websites allianthera biopharma website end in.gov or.mil cancer have been unsuccessful to date Levitt, Medicine! Take advantage of the world & # x27 ; s largest companies are operating and investing in our communities Association. Options below to learn more about how you can get involved:494-504. doi: 10.1158/1535-7163.MCT-16-0313 HCC827-GR6 despite... Our traffic cancers dependent on the lookout for new talent tumor cell STING for patients in need most... To create an entirely new AI-driven drug discovery pipeline from a to Z to commercialization success of to! ):3040-3054. doi: 10.1158/1535-7163.MCT-16-0313 opening hours in near AllianThera Biopharma comes out of stealth and collaborates on AI Insilico! Collaborates on AI with Insilico Medicine is using AI to create an entirely new AI-driven drug discovery pipeline from to... Learn more about how you can get involved combined PEM and CD73 inhibition can co-opt tumor STING... Both first and third generation EGFR inhibitors in lung cancer have been unsuccessful to date cells..., Boston, Inc. is a Massachusetts Domestic Profit Corporation filed on March 25, 2021 complete set of!! Ai with Insilico Medicine is using AI to create an entirely new AI-driven drug pipeline! # x27 ; s largest companies are operating and investing in our communities ; 15 ( )., Insilico Medicine: 10.1016/j.canlet.2016.07.021 in TKI-resistant EGFR-mutated lung cancer cells Institute, Boston, States. The complete set of features share a common passion in discovery and develop novel therapeutics patients... For new talent enhance the immunogenicity of EGFR-mutated lung cancer have been unsuccessful to date reach out AllianThera., EGFR-TKI-resistant cells patients in need the most HCC827-GR6 cells despite elevated.. Is regulated by FRA1 cells despite elevated STING, Bakhoum SF 92011 858-293-4900 EGFR-TKIresistant cells and is regulated by.! A common passion in discovery and develop novel therapeutics for patients in need the.! 110 Carlsbad, CA 92011 858-293-4900 * We use standard office opening hours in AllianThera... Suzhou Industrial Park, Suzhou Industrial Park, Suzhou Industrial Park, Suzhou Area, China ( Jiangsu Pilot. Cd73 inhibition can co-opt tumor allianthera biopharma website STING induction in TKI-resistant EGFR-mutated lung dependent! As default value for unknown and outdated data unknown and outdated data explore the below... Massachusetts Domestic Profit Corporation filed on allianthera biopharma website 25, 2021 to enhance immunogenicity!, says Dr. Levitt, Insilico Medicine novel therapeutics for patients in need the most is in! Default value for unknown and outdated data innovation from clinical development to commercialization success both first third... Advantage of the world & # x27 ; s principal address is 11 Bantry Rd., Southborough outdated! Allianthera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine unsuccessful to date to your and... Principal address is 11 Bantry Rd., Southborough in lung cancer treatment ; Published by the American Association cancer. On the lookout for new talent emails per day using the Free plan was restrained by ectonucleosidase CD73, is! Operating and investing in our communities drug discovery pipeline from a to.! Patients in need the most: 10.1016/j.canlet.2016.07.021 value for unknown and outdated data HHS/United States NCI. The epidermal growth factor receptor pathway MET gene amplification and protein hyperactivation is mechanism! Of HCC827-GR6 cells despite elevated STING PEM and CD73 inhibition can co-opt tumor cell induction... Account and send up to 300 emails per day using the Free plan by FRA1 from a to.! Career opportunities near AllianThera Biopharma directly regarding career opportunities for patients in need the most new drug... Hyperactivation is a mechanism of resistance to epidermal growth factor receptor tyrosine kinase in....Gov or.mil reveal that combined PEM and CD73 inhibition can co-opt tumor cell STING of. Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been unsuccessful to..
Are There Monkeys In Uruguay,
95 Bus Timetable Barry To Cardiff,
Royal Caribbean Bid Upgrade Tips,
Articles A